Skip to main content
release_alert
Welcome to the new Scholars 3.0! Read about new features and let us know what you think.
cancel

An Open-Label, Multicenter, Phase 2 Study of CLR 131 in Patients with Relapsed or Refractory (R/R) Select B-Cell Malignancies (CLOVER-1) and Expansion Cohort in Patients with Waldenstrom Macroglobulinemia (CLOVER-WaM)

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Cellectar Biosciences, Inc.

Start Date

March 9, 2023

End Date

March 31, 2028
 

Administered By

Duke Cancer Institute

Awarded By

Cellectar Biosciences, Inc.

Start Date

March 9, 2023

End Date

March 31, 2028